Valeritas adds ex-Insulet CCO Devlin to board
Valeritas said today it elected ex-Insulet (NSDQ:PODD) chief commercial officer Peter Devlin to its board of directors as an independent director. Prior to the move, Devlin was in charge of Insulet’s strategic and commercial plans, leading to an increase in annual sales from $30 million to nearly $300 million, the company said.
“Peter is a highly motivated, growth-driven leader with proven ability to develop and implement successful strategies for global healthcare markets across a variety of medical specialties. His breadth of commercial operational experience and his ability to develop and execute strategic partnerships will be extremely valuable to the Valeritas board. We are thrilled to welcome Peter to the Board, and we are certain that he will make significant contributions to the future growth of Valeritas,” CEO John Timberlake said in a prepared statement.
